Your browser doesn't support javascript.
loading
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.
Bauer, Axel; Schreinlechner, Michael; Sappler, Nikolay; Dolejsi, Theresa; Tilg, Herbert; Aulinger, Benedikt A; Weiss, Günter; Bellmann-Weiler, Rosa; Adolf, Christian; Wolf, Dominik; Pirklbauer, Markus; Graziadei, Ivo; Gänzer, Hannes; von Bary, Christian; May, Andreas E; Wöll, Ewald; von Scheidt, Wolfgang; Rassaf, Tienush; Duerschmied, Daniel; Brenner, Christoph; Kääb, Stefan; Metzler, Bernhard; Joannidis, Michael; Kain, Hans-Ulrich; Kaiser, Norbert; Schwinger, Robert; Witzenbichler, Bernhard; Alber, Hannes; Straube, Florian; Hartmann, Niels; Achenbach, Stephan; von Bergwelt-Baildon, Michael; von Stülpnagel, Lukas; Schoenherr, Sebastian; Forer, Lukas; Embacher-Aichhorn, Sabine; Mansmann, Ulrich; Rizas, Konstantinos D; Massberg, Steffen.
Afiliación
  • Bauer A; Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: axel.bauer@i-med.ac.at.
  • Schreinlechner M; Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Sappler N; Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Dolejsi T; Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Tilg H; Department of Internal Medicine I, Gastroenterology, Hepatology, and Endocrinology, Medical University of Innsbruck, Innsbruck, Austria.
  • Aulinger BA; Medizinische Klinik und Poliklinik II, LMU University Hospital Munich, Munich, Germany.
  • Weiss G; Department of Internal Medicine II, Infectious Diseases, Immunology, Rheumatology and Pneumology, Medical University of Innsbruck, Innsbruck, Austria.
  • Bellmann-Weiler R; Department of Internal Medicine II, Infectious Diseases, Immunology, Rheumatology and Pneumology, Medical University of Innsbruck, Innsbruck, Austria.
  • Adolf C; Medizinische Klinik und Poliklinik IV, LMU University Hospital Munich, Munich, Germany.
  • Wolf D; Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
  • Pirklbauer M; Department of Internal Medicine IV, Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria.
  • Graziadei I; Department of Internal Medicine, Hospital Hall in Tirol, Hall in Tirol, Austria.
  • Gänzer H; Department of Internal Medicine, Hospital Schwaz, Schwaz, Austria.
  • von Bary C; Department of Internal Medicine I, Rotkreuzklinikum Munich, Munich, Germany.
  • May AE; Department of Internal Medicine, Hospital Memmingen, Memmingen, Germany.
  • Wöll E; Department of Internal Medicine, Hospital Zams, Zams, Austria.
  • von Scheidt W; Department of Internal Medicine I, University Hospital Augsburg, Augsburg, Germany.
  • Rassaf T; Department of Cardiology and Vascular Medicine, West German Heart- and Vascular Center, University Duisburg-Essen, Essen, Germany.
  • Duerschmied D; University Heart Center Freiburg, Department of Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Brenner C; Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Kääb S; Medizinische Klinik und Poliklinik I, LMU University Hospital Munich, Munich, Germany; German Center for Cardiovascular Research, Munich Heart Alliance, Munich, Germany.
  • Metzler B; Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Joannidis M; Division of Intensive Care and Emergency Medicine, Department Internal Medicine, Medical University of Innsbruck, Innsbruck, Austria.
  • Kain HU; Department of Internal Medicine, Hospital Mühldorf, Mühldorf, Germany.
  • Kaiser N; Department of Internal Medicine, Hospital St Johann in Tirol, St Johann in Tirol, Austria.
  • Schwinger R; Department of Internal Medicine, Hospital Weiden, Weiden, Germany.
  • Witzenbichler B; Department of Internal Medicine, Hospital Dachau, Dachau, Germany.
  • Alber H; Department of Internal Medicine and Cardiology, Klinikum Klagenfurt am Woerthersee, Klagenfurt, Austria.
  • Straube F; Department of Cardiology and Internal Intensive Care Medicine, Munich Clinic Bogenhausen and Schwabing, Munich, Germany.
  • Hartmann N; Department of Internal Medicine I (Cardiology), University Hospital Aachen, Aachen, Germany.
  • Achenbach S; Department of Cardiology and Angiology, University Hospital Erlangen, Erlangen, Germany.
  • von Bergwelt-Baildon M; Medizinische Klinik und Poliklinik III, LMU University Hospital Munich, Munich, Germany.
  • von Stülpnagel L; Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria; Medizinische Klinik und Poliklinik I, LMU University Hospital Munich, Munich, Germany; German Center for Cardiovascular Research, Munich Heart Alliance, Munich, Germany.
  • Schoenherr S; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.
  • Forer L; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.
  • Embacher-Aichhorn S; Competence Center for Clinical Trials, Medical University of Innsbruck, Innsbruck, Austria.
  • Mansmann U; Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-University Munich, Germany.
  • Rizas KD; Medizinische Klinik und Poliklinik I, LMU University Hospital Munich, Munich, Germany; German Center for Cardiovascular Research, Munich Heart Alliance, Munich, Germany.
  • Massberg S; Medizinische Klinik und Poliklinik I, LMU University Hospital Munich, Munich, Germany; German Center for Cardiovascular Research, Munich Heart Alliance, Munich, Germany. Electronic address: steffen.massberg@med.uni-muenchen.de.
Lancet Respir Med ; 9(8): 863-872, 2021 08.
Article en En | MEDLINE | ID: mdl-34126053
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_arterial_hypertension / 6_cardiovascular_diseases / 6_other_respiratory_diseases Asunto principal: Sistema Renina-Angiotensina / Inhibidores de la Enzima Convertidora de Angiotensina / Antagonistas de Receptores de Angiotensina / SARS-CoV-2 / COVID-19 / Hipertensión Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_arterial_hypertension / 6_cardiovascular_diseases / 6_other_respiratory_diseases Asunto principal: Sistema Renina-Angiotensina / Inhibidores de la Enzima Convertidora de Angiotensina / Antagonistas de Receptores de Angiotensina / SARS-CoV-2 / COVID-19 / Hipertensión Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Año: 2021 Tipo del documento: Article